Zydus Lifesciences gets EIR from USFDA for Jarod injectable facility

04 Dec 2025 Evaluate

Zydus Lifesciences has received the Establishment Inspection Report (EIR) from the USFDA for a GMP follow-up inspection conducted at its injectable facility located at Jarod, Vadodara from August 25 to September 05, 2025 and classifying the facility as Voluntary Action Indicated (VAI). This inspection was conducted following the warning letter issued on August 29, 2024 by the USFDA.

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.

Zydus Lifesciences Share Price

934.30 -0.90 (-0.10%)
05-Dec-2025 13:36 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.00
Dr. Reddys Lab 1280.00
Cipla 1523.50
Zydus Lifesciences 934.30
Lupin 2102.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×